Mesothelioma Trials: CBP501, Pemetrexed and Cisplatin
Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.
If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.
The Japanese biotech research company CanBas Co. LTD is currently seeking patients in the U.S. to participate in clinical trials for an experimental drug called CBP501 in the treatment of malignant mesothelioma.
In the two phase trial, mesothelioma patients will be given doses of the experimental drug along with Pemetrexed and Cisplatin. The purpose of the study is to determine the maximum tolerable dose of the three drugs and the effectiveness of the drugs in the treatment of mesothelioma.
The study is being conducted at the following hospitals: Nevada Cancer Institute, Las Vegas, Nevada; University of New Mexico Cancer Center, Albuquerque, NM; Memorial-Sloane Kettering Cancer Center, New York, NY; Penn State Milton S. Hershey Medical Center, Hershey, PA; and the Cancer Therapy & Research Center; San Antonio, TX.
Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.
If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.